Indigo Diabetes
0666.442.557 · rovalta.com · 25/09/2026
ACTIVE
Indigo Diabetes
Financial year 2025 · Closed on 31/12/2025
Net result-5,2 M €-27,3 %over 1 year
Revenue1,5 k €
Equity-1,7 M €-148,0 %over 1 year
Workforce11,1 ETP-30,2 %over 1 year
Overview
Identity
Source · BCE/KBOIndigo Diabetes is a Public limited company incorporated in 2016. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Gent. It employs on average 11,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0666.442.557
- Incorporation
- 17/11/2016
- Legal form
- Public limited company
- Registered office
- Bollebergen 2B box 5
9052 Gent · FlandreSee on map - Contributed capital
- 6 858 117,59 €
- Latest accounts
- 31/12/2025
- Average workforce
- 11,1 ETP
Activities (NACE)
Joint committees (2)
- 207
- 20700
Signals
Healthy social debts
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 1,5 k € | – | – | – | – | ||||
| EBITDA | -2,9 M € | -19.6% | -2,5 M € | +54.9% | -5,5 M € | +29.2% | -7,7 M € | -69.1% | -4,6 M € |
| Operating result | -5,4 M € | -21.7% | -4,5 M € | +59.8% | -11,1 M € | +7.4% | -12 M € | -32.5% | -9,1 M € |
| Net result | -5,2 M € | -27.3% | -4,1 M € | +60.8% | -10,4 M € | +20.3% | -13,1 M € | -80.6% | -7,2 M € |
| Balance sheet | |||||||||
| Equity | -1,7 M € | -148% | 3,6 M € | -9.7% | 4 M € | -70.7% | 13,7 M € | +32.4% | 10,3 M € |
| Total assets | 5 M € | +19.1% | 4,2 M € | -18.2% | 5,1 M € | -68.0% | 16,1 M € | +32.1% | 12,2 M € |
| Cash | 2,5 M € | +129% | 1,1 M € | -35.7% | 1,7 M € | -86.2% | 12,5 M € | +68.4% | 7,4 M € |
| Debts | 6,7 M € | +1067% | 576,7 k € | -46.5% | 1,1 M € | -50.9% | 2,2 M € | +42.1% | 1,5 M € |
| Other | |||||||||
| Workforce | 11,1 ETP | -30.2% | 15,9 ETP | -50.2% | 31,9 ETP | -2.1% | 32,6 ETP | +16.0% | 28,1 ETP |
Board of directors
Source · NBB, accounts to 31/12/20255 active · 34 ended
Active mandates
Charles-Lambert Beauduin
ActiveActive
Active
Active
Ended mandates
Other companies at this address
Bollebergen 2B 9052 Gent| Company | CBE no. |
|---|---|
| 0776.661.380 | |
TESCAN XRE● Active | 0839.520.152 |
| 0459.285.397 | |
Virtual International Academy● Active | 0685.982.119 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/05/2026 | 23/04/2025 | 15/05/2024 | 23/05/2023 | 05/08/2022 | 27/05/2021 |
| General meeting | 28/04/2026 | 22/04/2025 | 13/05/2024 | 25/04/2023 | 08/07/2022 | 27/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 28/04/2026 | 21/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 22/04/2025 | 23/04/2025 | Dutch | |
| Abridged model | 31/12/2023 | 13/05/2024 | 15/05/2024 | Dutch | |
| Abridged model | 31/12/2022 | 25/04/2023 | 23/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 08/07/2022 | 05/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 27/04/2021 | 27/05/2021 | Dutch | |
| Abridged model | 31/12/2019 | 28/04/2020 | 19/05/2020 | Dutch | |
| Abridged model | 31/12/2018 | 23/04/2019 | 22/05/2019 | Dutch | |
| Abridged model | 31/12/2017 | 24/04/2018 | 23/05/2018 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 34 ended
Active mandates
Charles-Lambert Beauduin
ActiveActive
Active
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates15/04/2026ONTSLAGEN - BENOEMINGEN
- Mandates04/04/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates25/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates26/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates23/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates30/03/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares21/12/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
- Mandates19/09/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-5,2 M €↓
- 2024Annual accounts 2024-4,1 M €↑
- 2023Annual accounts 2023-10,4 M €↑
- 2022Annual accounts 2022-13,1 M €↓
- 2021Annual accounts 2021-7,2 M €↓
- 2020Annual accounts 2020-6,2 M €↓
- 2019Annual accounts 2019-2,1 M €↑
- 2018Annual accounts 2018-3,3 M €↓
- 2017Annual accounts 2017-1,6 M €
- 17/11/2016IncorporationPublic limited company